摘要
Dear Editor,Since December 2019,severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has been rapidly spreading worldwide.Hydroxychloroquine and chloroquine are candidates for the treatment of coronavirus disease 2019(COVID-19)owing to its antiviral effect and immunomodulation properties.
基金
supported by MOST(Ministry of Science and Technology of the People's Republic of China)foundation for SARS-Co V-2 Research(2020YFC0844500)
the“13th Five-Year”National Science and Technology Major Project of China(2017ZX09101001-002-001,2017ZX09304012)
Peking University Health Center Foundation for Combating the Pandemic Programs(BMU2020HKYZX011)。
